Freedman Financial Associates, Inc. Gsk PLC Transaction History

Freedman Financial Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$38.79 - $43.16 $2,715 - $3,021	-70 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$36.52 - $41.46 $2,556 - $2,902	70 New	70 $3,000
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $6,854 - $8,002	-200 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$34.07 - $39.94 $6,814 - $7,988	200 New	200 $7,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Freedman Financial Associates, Inc. with notifications on news.